AMS BioteQ, a company listed under stock code 6864, has made significant progress in the Japanese healthcare sector by showcasing its innovative technologies and flexible production capabilities at Medical Japan 2024.
The event served as a platform for the company to present its latest healthcare solutions, including advanced medical wound care dressings and post-operative recovery products.
Dr. Yiju Tsai, the founder and Chairman of AMS BioteQ, emphasized the company's international strategy and core technologies, highlighting its commitment to establishing a strong market presence in Japan.
The primary objectives of AMS BioteQ at the exhibition were to enhance brand reputation, connect with local drug and medical dressing markets, identify distribution partners, and pursue collaborations in drug development.
Dr. Tsai expressed the company's ambition to lay a solid foundation in Japan, which would serve as a springboard for global expansion.
The global chronic wound care market is growing rapidly due to factors such as the increasing prevalence of diabetes, an aging population, and improved detection methods for chronic wounds.
AMS BioteQ is well-positioned to capitalize on this growing market with its innovative product offerings.
The company has successfully launched two key products: SIPSIP Foam and SIPSIP Pro Gel Dressings.
Japan's healthcare market is known for its stringent quality requirements and high entry barriers, which can pose challenges for foreign companies.
To facilitate effective communication and demonstrate its dedication to understanding Japanese culture, AMS BioteQ deployed a team fluent in Japanese at the exhibition.
As AMS BioteQ continues to attract attention in Japan with its innovative dressing technology and advancements in post-operative recovery solutions, the company is poised to make significant progress in the Japanese healthcare market.
Collaborations with local pharmaceutical companies are expected to progress, further enhancing AMS BioteQ's presence and enabling the company to expand its technologies on a global scale.
The focus on innovative medical materials and drug development aligns with the growing demand for effective healthcare solutions, positioning AMS BioteQ as a key player in the evolving landscape of the healthcare industry.